These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 45391)

  • 21. Inhibition of dopamine uptake by a new psychostimulant mesocarb (Sydnocarb).
    Erdö SL; Kiss B; Rosdy B
    Pol J Pharmacol Pharm; 1981; 33(2):141-7. PubMed ID: 7312716
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of platelet aggregation and stimulation of guanylate cyclase by an antianginal agent molsidomine and its metabolites.
    Nishikawa M; Kanamori M; Hidaka H
    J Pharmacol Exp Ther; 1982 Jan; 220(1):183-90. PubMed ID: 6118429
    [No Abstract]   [Full Text] [Related]  

  • 23. [Vectorgraphic assessment of the influence of different psychic stimulators on the avoidance behavior of rats].
    Arushanian EK; Baturin VA
    Biull Eksp Biol Med; 1977 Sep; 84(9):303-6. PubMed ID: 912085
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Experience with new psychostimulant - Sydnocarb].
    Bach O; Petermann H; Heber I
    Psychiatr Neurol Med Psychol (Leipz); 1976 Oct; 28(10):609-14. PubMed ID: 798218
    [No Abstract]   [Full Text] [Related]  

  • 25. [Structural investigations of one of the major metabolites of "Sydnocarb" with the MS, IR, and NMR methods].
    Czira G; Polgár M; Tamás J; Holly S; Radics L; Vereczkey L
    Acta Pharm Hung; 1978; 48 Suppl():25-6. PubMed ID: 749522
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effects of antagonists of the various subtypes of dopamine receptors on the locomotor activity of C57BL mice induced by psychostimulators].
    Novoselov IA; Raevskiĭ KS
    Eksp Klin Farmakol; 2003; 66(6):3-5. PubMed ID: 14743700
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Radiochromatographic study of the distribution of sidnocarb-14C and its metabolites in inbred mice].
    Seredenin SB; Rybina IV
    Farmakol Toksikol; 1985; 48(4):79-83. PubMed ID: 4043368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Locomotor activity and expression of c-Fos protein in the brain of C57BL and Balb/c mice: effects of D-amphetamine and sydnocarb].
    Novoselov IA; Cherepov AB; Raevskiĭ KS; Anokhin KV
    Eksp Klin Farmakol; 2002; 65(5):18-21. PubMed ID: 12596507
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Sydnones and sydnonimines. Chemistry and pharmacology].
    Bös M; Fleischhacker W
    Pharm Unserer Zeit; 1984 Mar; 13(2):51-6. PubMed ID: 6718443
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effect of Molsidomin on the hemodynamics and working tolerance of patients with angina pectoris].
    Slany J; Mösslacher H; Schmoliner R; Krinik G
    Med Welt; 1976 Dec; 27(49):2396-2400. PubMed ID: 796622
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effect of sidnocarb during 7-day water immersion on the cardiorespiratory system under physical load].
    Anashkin OD; Beliaev SM
    Kosm Biol Aviakosm Med; 1982; 16(6):28-31. PubMed ID: 7176502
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effects of sidnocarb on hemodynamics and blood redistribution during functional tests after 6-hour antiorthostatic hypokinesis].
    Modin AIu; Abrosimov SV; Amel'kina GV; Anashkin OD; Zhidkov VV
    Kosm Biol Aviakosm Med; 1983; 17(6):36-9. PubMed ID: 6656184
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiovascular pharmacology of molsidomine.
    Thulesius O
    Bibl Cardiol; 1984; (38):234-43. PubMed ID: 6398071
    [No Abstract]   [Full Text] [Related]  

  • 34. [Influence of aspirin on the hemodynamic effects of molsidomine in healthy volunteers].
    Weber S; de Lauture D; Puechavy C; Pipeau C; Chazelle F; Degeorges M
    Therapie; 1986; 41(3):153-7. PubMed ID: 3529482
    [No Abstract]   [Full Text] [Related]  

  • 35. [Symposium on molsidomin in Moscow. Analysis of a drug against coronary disease].
    MMW Munch Med Wochenschr; 1979 Sep; 121(36):1128. PubMed ID: 114780
    [No Abstract]   [Full Text] [Related]  

  • 36. Hemodynamic effects of molsidomine.
    Rakovec P
    J Cardiovasc Pharmacol; 1980; 2(6):893-4. PubMed ID: 6160337
    [No Abstract]   [Full Text] [Related]  

  • 37. [Reduction of pre-loading with sublingual molsidomin. Effect on systole-diastole time intervals].
    Romano M; Guerra G; Abita R; Chiariello M
    Minerva Cardioangiol; 1984; 32(1-2):67-71. PubMed ID: 6546975
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effect of dihydroergotamine and sidnocarb on human orthostatic tolerance in head-down-tilt hypokinesia].
    Anashkin OD; Modin AIu
    Kosm Biol Aviakosm Med; 1983; 17(3):83-4. PubMed ID: 6876726
    [No Abstract]   [Full Text] [Related]  

  • 39. [Peripheral cholinolytic action--one of the effects of sidnofen].
    Samonina GE; Mandriko EV
    Biull Eksp Biol Med; 1989 Apr; 107(4):449-51. PubMed ID: 2720163
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Changes in membrane proteins in the brain stem of the rat after deprivation of the paradoxical stage of sleep and prolongation of this stage during subsequent free behavior].
    Demin NN; Shelepina EP; Nerobkova LN; Krapivin SV; Voronina TA
    Fiziol Zh SSSR Im I M Sechenova; 1986 Jun; 72(6):723-8. PubMed ID: 3732547
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.